Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KISS1R | Q969F8 | 5/20 | 0.54 |
| ▸ | NPY1R | P25929 | 3/20 | 0.50 |
| ▸ | NPY2R | P49146 | 3/20 | 0.50 |
| ▸ | NPY4R | P50391 | 3/20 | 0.50 |
| ▸ | IL23R | Q5VWK5 | 2/20 | 0.50 |
| ▸ | ACE | P12821 | 2/20 | 0.50 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | MAGI3 | Q5TCQ9 | 1/20 | 0.49 |
| ▸ | ECE1 | P42892 | 1/20 | 0.49 |
| ▸ | C5AR1 | P21730 | 1/20 | 0.49 |
| ▸ | CD47 | Q08722 | 1/20 | 0.49 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29799939 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL30305322 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL30305637 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL30305270 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL30456528 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL30305302 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL30340404 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL29732503 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL29732780 | 1.00 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R | |
| SCHEMBL30092900 | 0.98 | KISS1R (0.54) | KISS1RNPY1RNPY2RNPY4RIL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4401752-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | Peptilogics, Inc. (US) | 2024-07-24 | — | — | EP | claimed |
| WO-2023044423-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | PEPTILOGICS, INC. (US) | 2023-03-23 | — | — | WO | claimed |
| US-20250320266-A1 | Methods and Compositions for Treatment of Antibiotic-Resistant Bacterial Infections | UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION (US) | 2025-10-16 | — | — | US | disclosed |
| US-12371463-B2 | Methods and compositions for treatment of antibiotic-resistant bacterial infections | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2025-07-29 | — | — | US | disclosed |
| EP-4401752-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | Peptilogics, Inc. (US) | 2024-07-24 | — | — | EP | disclosed |
| WO-2023044423-A1 | ENGINEERED ANTIMICROBIAL PEPTIDES AND USAGE THEREOF | PEPTILOGICS, INC. (US) | 2023-03-23 | — | — | WO | disclosed |
| US-20220332777-A1 | Methods and Compositions for Treatment of Antibiotic-Resistant Bacterial Infections | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2022-10-20 | — | — | US | disclosed |